- Home
- SRL vs COEP Comparison
SRL vs COEP Comparison
Compare SRL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- COEP
- Stock Information
- Founded
- SRL 2017
- COEP 2017
- Country
- SRL China
- COEP United States
- Employees
- SRL N/A
- COEP N/A
- Industry
- SRL Professional Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRL Consumer Discretionary
- COEP Health Care
- Exchange
- SRL Nasdaq
- COEP Nasdaq
- Market Cap
- SRL 81.5M
- COEP 86.0M
- IPO Year
- SRL N/A
- COEP N/A
- Fundamental
- Price
- SRL N/A
- COEP $16.76
- Analyst Decision
- SRL
- COEP
- Analyst Count
- SRL 0
- COEP 0
- Target Price
- SRL N/A
- COEP N/A
- AVG Volume (30 Days)
- SRL 8.4K
- COEP 65.4K
- Earning Date
- SRL 04-30-2025
- COEP 11-12-2025
- Dividend Yield
- SRL 18.91%
- COEP N/A
- EPS Growth
- SRL N/A
- COEP N/A
- EPS
- SRL N/A
- COEP N/A
- Revenue
- SRL $24,535,042.00
- COEP $263,555.00
- Revenue This Year
- SRL N/A
- COEP N/A
- Revenue Next Year
- SRL N/A
- COEP N/A
- P/E Ratio
- SRL N/A
- COEP N/A
- Revenue Growth
- SRL N/A
- COEP N/A
- 52 Week Low
- SRL $5.13
- COEP $2.31
- 52 Week High
- SRL $9.99
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- SRL 46.42
- COEP 60.80
- Support Level
- SRL $5.48
- COEP $16.00
- Resistance Level
- SRL $6.00
- COEP $18.15
- Average True Range (ATR)
- SRL 0.44
- COEP 1.60
- MACD
- SRL -0.02
- COEP 0.07
- Stochastic Oscillator
- SRL 10.67
- COEP 66.80
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.